Cuu Long Pharmaceutical Joint Stock Company provided earnings guidance for the fiscal year 2022. For the period, the company expects net revenue to be VND 845,510 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27,300 VND | 0.00% | +5.00% | +9.20% |
1st Jan change | Capi. | |
---|---|---|
+9.20% | 78.71M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- DCL Stock
- News Cuu Long Pharmaceutical
- Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022